Declomycin: Uses, Side Effects & Dosage Information

Declomycin, also known as demeclocycline, is a broad-spectrum tetracycline antibiotic used to treat a wide variety of bacterial infections. This comprehensive guide covers the essential information about Declomycin, including its uses, side effects, dosage, and other important details.

Introduction to Declomycin

Declomycin is a semisynthetic tetracycline antibiotic isolated from a mutant strain of Streptomyces aureofaciens. It belongs to the tetracycline class of antibiotics, which are known for their broad-spectrum activity against various types of bacteria. Demeclocycline“> Declomycin is chemically known as 7-chloro-6-demethyltetracycline or RP-10192, and its IUPAC name is (4S,4aR,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide.

Chemical Composition

Declomycin is a yellow, crystalline compound with a molecular formula of C ₂₁H ₂₁ClN ₂O ₈. Its chemical structure consists of a linear fused tetracyclic nucleus with various substitutions, including a chlorine atom at the 7th position and a dimethylamino group at the 4th position. Demeclocycline is the hydrochloride salt form of Declomycin, which enhances its water solubility and bioavailability.

Mechanism of Action

Declomycin, like other tetracycline antibiotics, works by inhibiting bacterial protein synthesis. It binds to the 30S subunit of the bacterial ribosome and prevents the attachment of aminoacyl-tRNA to the ribosome, thereby stopping bacterial growth and reproduction. Declomycin is effective against a wide range of gram-positive and gram-negative bacteria, including Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, and Haemophilus influenzae.

Indications and Uses

Declomycin is primarily used to treat various bacterial infections, such as:

• Acne vulgaris
• Urinary tract infections
• Respiratory tract infections (e.g., pneumonia, bronchitis)
• Skin and soft tissue infections
• Sexually transmitted infections (e.g., gonorrhea, syphilis)
• Ophthalmic infections (e.g., trachoma)

Additionally, Declomycin has been used in the detection of bone growth in patients receiving bisphosphonate therapy for conditions like Paget’s disease or osteoporosis.

Dosage and Administration

The recommended dosage of Declomycin varies depending on the age, weight, and condition being treated. For most bacterial infections, the typical adult dosage is 150 mg to 300 mg every 6 to 8 hours or 300 mg to 600 mg every 12 hours. Pediatric dosages are based on body weight, with the typical range being 3 mg/kg to 6 mg/kg per day, divided into three or four doses.

Declomycin is available in tablet and capsule forms and should be taken with a full glass of water, preferably on an empty stomach. It is important to complete the full course of treatment as prescribed to prevent the development of antibiotic resistance.

Side Effects

Like other tetracycline antibiotics, Declomycin may cause various side effects, including:

• Common side effects: nausea, vomiting, diarrhea, loss of appetite, skin rash, and photosensitivity.
• Serious side effects: liver toxicity, pancreatitis, blood disorders (e.g., hemolytic anemia, thrombocytopenia), and allergic reactions (e.g., anaphylaxis).

It is important to report any severe or persistent side effects to your healthcare provider.

Warnings and Precautions

Declomycin should be used with caution in certain populations and conditions, such as:

• Pregnancy and breastfeeding: Declomycin can cross the placenta and enter breast milk, potentially causing adverse effects in the fetus or nursing infant.
• Kidney or liver impairment: Dosage adjustments may be required in patients with renal or hepatic dysfunction.
• Pediatric use: Declomycin may cause permanent tooth discoloration and enamel hypoplasia in children under 8 years old.
• Photosensitivity: Declomycin can increase sensitivity to sunlight, leading to sunburn or skin reactions.

Patients should inform their healthcare providers about any medical conditions, allergies, or medications they are taking to avoid potential interactions or adverse effects.

armacokinetics”> armacokinetics/”>Ph armacokinetics

Declomycin is well-absorbed from the gastrointestinal tract, with a bioavailability of around 60-70%. It is widely distributed throughout the body tissues and fluids, including the cerebrospinal fluid. Declomycin is metabolized in the liver and excreted primarily through the kidneys.

The half-life of Declomycin is approximately 10-16 hours, allowing for once or twice-daily dosing. However, dosage adjustments may be necessary in patients with renal or hepatic impairment.

Contraindications

Declomycin should not be used in patients with known hypersensitivity or allergy to tetracycline antibiotics. It is also contraindicated in pregnant women and children under 8 years old due to the risk of permanent tooth discoloration and enamel hypoplasia.

Comparisons with Other Tetracyclines

Declomycin shares many similarities with other tetracycline antibiotics, such as doxycycline and tetracycline. However, it has some unique properties that distinguish it from these related compounds:

• Declomycin has a longer half-life compared to tetracycline, allowing for less frequent dosing.
• It has a slightly broader spectrum of activity against certain gram-negative bacteria compared to tetracycline.
• Declomycin may be associated with a lower risk of photosensitivity reactions compared to some other tetracyclines.

Patient Information

Patients taking Declomycin should follow the instructions provided by their healthcare provider carefully. They should take the medication with a full glass of water, preferably on an empty stomach, and complete the full course of treatment to prevent antibiotic resistance.

If a dose is missed, patients should take it as soon as possible, unless it is almost time for the next dose, in which case they should skip the missed dose and continue with the regular schedule.

In case of an overdose, patients should seek immediate medical attention or contact a poison control center.

Research and Development

Declomycin was first isolated in the late 1950s and has been extensively studied for its antibacterial properties and potential applications. Recent research has focused on exploring its use in the detection of bone growth in patients receiving bisphosphonate therapy, as well as investigating its potential as an adjunctive therapy in various medical conditions.

Legal and Regulatory Status

Declomycin is an FDA-approved antibiotic and has been available for clinical use since the 1960s. However, due to the availability of newer tetracycline antibiotics and changing prescribing patterns, it may not be widely available in all regions or countries.

Generic vs. Brand Name

Declomycin is available as both brand-name and generic formulations. The brand name Declomycin is no longer marketed, but generic demeclocycline hydrochloride products are available from various manufacturers.

Cost and Availability

The cost of Declomycin or generic demeclocycline can vary depending on the region, formulation, and manufacturer. As a generic medication, it is generally more affordable than brand-name alternatives. However, its availability may be limited in some areas due to changing prescribing patterns and the introduction of newer tetracycline antibiotics.

Patient Reviews and Experiences

Patient reviews and experiences with Declomycin can provide valuable insights into its real-world use and effectiveness. While some patients have reported positive outcomes in treating various bacterial infections, others have experienced side effects such as nausea, diarrhea, and photosensitivity reactions.

It is important to note that individual responses to medications can vary, and patients should consult their healthcare providers for personalized advice and monitoring.